The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients

被引:5
|
作者
Casteleijn, Niek F. [1 ]
Geertsema, Paul [2 ]
Koorevaar, Iris W. [2 ]
Inkelaar, Friso D. J. [2 ]
Jansen, Marnix R. [2 ]
Lohuis, Steven J. [2 ]
Meijer, Esther [2 ]
Pol, Robert A. [3 ]
Sanders, Jan-Stephan [2 ]
van de Streek, Peter E. [2 ]
Leliveld, Anna M. [1 ]
Gansevoort, Ron T. [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Urol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
关键词
Autosomal dominant polycystic kidney disease; Polycystic kidney disease; Nephrectomy; Transplantation;
D O I
10.1159/000525575
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: There is no consensus if nor when a native nephrectomy should be performed in the workup for kidney transplantation in ADPKD patients. In our PKD Expertise Center, a restrictive approach is pursued in which nephrectomy is performed only in patients with severe complaints, i.e., in case of serious volume-related complaints, lack of space for the allograft, recurrent cyst infections, persistent cyst bleedings, or chronic refractory pain. We analyzed in a retrospective cohort study whether this approach is justified. Methods: All ADPKD patients who received kidney transplantation between January 2000 and January 2019 were reviewed. Patients were subdivided into three groups: no nephrectomy (no-Nx), nephrectomy performed before (pre-Tx), or after kidney transplantation (post-Tx). Simultaneous nephrectomy together with transplantation were not performed in our center. Results: 391 patients (54 +/- 9 years, 55% male) were included. The majority of patients did not undergo a nephrectomy (n = 257, 65.7%). A nephrectomy was performed pre-Tx in 114 patients (29.2%). After Tx, nephrectomy was performed in only 30 patients (7.7%, median 4.4 years post-Tx). Surgery-related complication rates did not differ between both groups (38.3% pre-Tx vs. 27.0% post-Tx, p = 0.2), nor were there any differences in 10-year patient survival (74.4% pre-Tx vs. 80.7% post-Tx vs. 67.6% no-Nx, p = 0.4), as well as in 10-year death-censored graft survival (84.4% pre-Tx vs. 85.5% post-Tx vs. 90.0% no-Nx, p = 0.9). Conclusions: This study indicates that with a restrictive nephrectomy policy in the workup for kidney transplantation, only a part of ADPKD patients need a native nephrectomy.
引用
收藏
页码:148 / 156
页数:9
相关论文
共 50 条
  • [41] Recognizing and treating autosomal dominant polycystic kidney disease
    Uko, Chigozie G.
    NURSE PRACTITIONER, 2020, 45 (11) : 41 - 47
  • [42] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Tomoyuki Kawada
    Clinical and Experimental Nephrology, 2016, 20 : 147 - 148
  • [43] Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease
    Stayner, Cherie
    Brooke, Darby G.
    Bates, Michael
    Eccles, Michael R.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (17) : 3081 - 3102
  • [44] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Kawada, Tomoyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (01) : 147 - 148
  • [45] Kidney volume and function in autosomal dominant polycystic kidney disease
    Higashihara, Eiji
    Nutahara, Kikuo
    Okegawa, Takatsugu
    Shishido, Toshihide
    Tanbo, Mitsuhiro
    Kobayasi, Kuninori
    Nitadori, Toshiaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (01) : 157 - 165
  • [46] Mortality risk in patients with autosomal dominant polycystic kidney disease
    Mladsi, Deirdre
    Zhou, Xiaolei
    Mader, Gregory
    Sanon, Myrlene
    Wang, Jinyi
    Barnett, Christine
    Willey, Cynthia
    Seliger, Stephen
    BMC NEPHROLOGY, 2024, 25 (01)
  • [47] Glioma in Patients with Autosomal-Dominant Polycystic Kidney Disease
    Hao, Shuyu
    Feng, Jie
    Park, Deric M.
    Gao, Zhixian
    WORLD NEUROSURGERY, 2017, 98 : 885.e1 - 885.e5
  • [48] Autosomal dominant polycystic kidney disease in a kidney transplant population
    Hadimeri, H
    Norden, G
    Friman, S
    Nyberg, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (07) : 1431 - 1436
  • [49] Autophagy and Autosomal Dominant Polycystic Kidney Disease
    Oto, Ozgur Akin
    Edelstein, Charles L.
    TURKISH JOURNAL OF NEPHROLOGY, 2023, 32 (01): : 8 - 15
  • [50] Hypertension in Autosomal Dominant Polycystic Kidney Disease
    Chapman, Arlene B.
    Stepniakowski, Konrad
    Rahbari-Oskoui, Frederic
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 153 - 163